Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2020

Nov 20, 2020

33018_dirs_2020-11-19_f748d72c-417a-483b-992a-d50c2e1af243.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2020-11-10

Reporting Person: Guttman-McCabe Christopher (Chief Reg & Comm Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 45610 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $25.75 2027-02-27 Common Stock (11750) Direct
Stock Option (Right to Buy) $32.50 2028-02-05 Common Stock (8000) Direct
Stock Option (Right to Buy) $42.14 2029-02-11 Common Stock (6715) Direct
Stock Option (Right to Buy) $34.40 2030-10-21 Common Stock (62500) Direct

Footnotes

F1: Includes Restricted Stock Units in the amounts of (i) 5,000 shares vesting on December 15, 2020 and (ii) 30,572 shares that will vest in 4 equal annual installments beginning on November 15, 2021. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock.

F2: The option shares are fully vested.

F3: The option shares vest and become exercisable in 4 equal annual installments beginning on November 15, 2021.